Bortezomib Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 3.5 mg/vial

Reference Brands: Velcade (USA/EU)

Category: Oncology Cancer Care

Bortezomib is a proteasome inhibitor used in the treatment of multiple myeloma and mantle cell lymphoma. It works by blocking proteasomes, the enzyme complexes responsible for breaking down proteins in cells, which leads to cancer cell death. Marketed under the brand name Velcade, it is available as a 3.5 mg/vial powder for injection for intravenous or subcutaneous use. It is an essential drug in modern cancer chemotherapy regimens. Bortezomib is available in Injection and strengths such as 3.5 mg/vial. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Bortezomib is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Bortezomib can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.